Advanced search
Publication Cover
Melanoma Management Volume 3, 2016 - Issue 4
Submit an article Journal homepage
28
Views
1
CrossRef citations to date
0
Altmetric
Editorial

The use of Dendritic Cell Vaccinations in Melanoma: Where are we Now?

Altuna Halilovic1 Department of Tumor Immunology,Radboud Institute for Molecular Life Sciences,Radboud University Medical Center,Nijmegen,The Netherlands;2 Department of Pathology,Radboud Institute for Molecular Life Sciences,Radboud University Medical Center,Nijmegen,The NetherlandsView further author information
&
Kalijn F Bol1 Department of Tumor Immunology,Radboud Institute for Molecular Life Sciences,Radboud University Medical Center,Nijmegen,The Netherlands;3 Department of Medical Oncology,Radboud University Medical Center,Nijmegen,The NetherlandsCorrespondence[email protected]
View further author information
Pages 247-250 | Received 20 Jul 2016, Accepted 18 Aug 2016, Published online: 29 Nov 2016

References

  • Banchereau J , SteinmanRM. Dendritic cells and the control of immunity. Nature392 (6673), 245 – 252 (1998).
  • Palucka K , BanchereauJ. Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer12 (4), 265 – 277 (2012).
  • Schreibelt G , BolKF, WestdorpHet al. Effective clinical responses in metastatic melanoma patients after vaccination with primary myeloid dendritic cells. Clin. Cancer Res.22 (9), 2155 – 2166 (2016).
  • Bol KF , SchreibeltG, GerritsenWR, De VriesIJ, FigdorCG. Dendritic cell-based immunotherapy: state of the art and beyond. Clin. Cancer Res.22 (8), 1897 – 1906 (2016).
  • Lesterhuis WJ , AarntzenEH, De VriesIJet al. Dendritic cell vaccines in melanoma: from promise to proof? Crit. Rev. Oncol. Hematol. 66 (2), 118 – 134 (2008).
  • De Vries IJ , LesterhuisWJ, ScharenborgNMet al. Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. Clin. Cancer Res.9 (14), 5091 – 5100 (2003).
  • Carreno BM , MagriniV, Becker-HapakMet al. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science348 (6236), 803 – 808 (2015).
  • De Vries IJ , BernsenMR, LesterhuisWJet al. Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome. J. Clin. Oncol.23 (24), 5779 – 5787 (2005).
  • Aarntzen EH , BolK, SchreibeltGet al. Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-based vaccination in metastatic melanoma. Cancer Res.72 (23), 6102 – 6110 (2012).
  • Hsu FJ , BenikeC, FagnoniFet al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med.2 (1), 52 – 58 (1996).
  • Anguille S , SmitsEL, LionE, Van TendelooVF, BernemanZN. Clinical use of dendritic cells for cancer therapy. Lancet Oncol.15 (7), e257 – e267 (2014).
  • Schadendorf D , UgurelS, Schuler-ThurnerBet al. Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann. Oncol.17 (4), 563 – 570 (2006).
  • Bol KF , AarntzenEH, HoutFEet al. Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination. Oncoimmunology5 (1), e1057673 (2016).
  • Tel J , AarntzenEH, BabaTet al. Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients. Cancer Res.73 (3), 1063 – 1075 (2013).
  • Sharma P , AllisonJP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell161 (2), 205 – 214 (2015).
  • Ribas A , Comin-AnduixB, ChmielowskiBet al. Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Clin. Cancer Res.15 (19), 6267 – 6276 (2009).
  • Wilgenhof S , CorthalsJ, HeirmanCet al. Phase II study of autologous monocyte-derived mRNA electroporated dendritic cells (trimixdc-mel) plus ipilimumab in patients with pretreated advanced melanoma. J. Clin. Oncol.34 (12), 1330 – 1338 (2016).
  • Bakdash G , SchreursI, SchreibeltG, TelJ. Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy. Expert Rev. Clin. Immunol.10 (7), 915 – 926 (2014).
  • Dhodapkar MV , SznolM, ZhaoBet al. Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205. Sci. Transl. Med.6 (232), 232ra251 (2014).
  • Kranz LM , DikenM, HaasHet al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature534 (7607), 396 – 401 (2016).
  • Vasaturo A , HalilovicA, BolKFet al. T-cell landscape in a primary melanoma predicts the survival of patients with metastatic disease after their treatment with dendritic cell vaccines. Cancer Res.76 (12), 3496 – 3506 (2016).
  • Boudewijns S , WestdorpH, KoornstraRHet al. Immune-related adverse events of dendritic cell vaccination correlate with immunologic and clinical outcome in stage III and IV melanoma patients. J. Immunother.39 (6), 241 – 248 (2016).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.